GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates

Company Performance - GE HealthCare Technologies (GEHC) reported quarterly earnings of $1.06 per share, exceeding the Zacks Consensus Estimate of $0.91 per share, and showing an increase from $1 per share a year ago, resulting in an earnings surprise of +16.48% [1] - The company posted revenues of $5.01 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.66%, and up from $4.84 billion year-over-year [2] - Over the last four quarters, GE HealthCare has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] Stock Performance and Outlook - GE HealthCare shares have declined approximately 0.6% since the beginning of the year, while the S&P 500 has gained 8.3% [3] - The company's current Zacks Rank is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] - The current consensus EPS estimate for the upcoming quarter is $0.94 on revenues of $5.02 billion, and for the current fiscal year, it is $4.02 on revenues of $20.31 billion [7] Industry Context - The Medical - Products industry, to which GE HealthCare belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact GE HealthCare's stock performance [5]